From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 1, 2011, Pages 1-10

  Martinez, Ariel F ^a   Muenke, Maximilian ^a   Arcos Burgos, Mauricio ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

latrotoxin; ADHD; G protein coupled receptor; Latrophilin; LPHN3

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALCOHOL; ALPHA LATROTOXIN; CHLORINE; DOXORUBICIN; ETHINYLESTRADIOL; FLUOROURACIL; G PROTEIN COUPLED RECEPTOR; LATROPHILIN; METHOTREXATE; MUSTARD GAS; NEUROTRANSMITTER; OZONE; PALM OIL; PARACETAMOL; PARAQUAT; UNCLASSIFIED DRUG; VALPROIC ACID; VINCLOZOLIN; ALPHA LATROTOXIN RECEPTOR; ALPHA-LATROTOXIN RECEPTOR; RECEPTOR; SPIDER VENOM;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHEMICAL STRUCTURE; FAT INTAKE; HORMONE RELEASE; HUMAN; LATRODECTUS; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERTEBRATE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; INTRACELLULAR SPACE; METABOLISM; MOLECULAR GENETICS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; INTRACELLULAR SPACE; MENTAL DISORDERS; MOLECULAR SEQUENCE DATA; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION; SPIDER VENOMS;

EID: 79953323334     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31137     Document Type: Article

References (117)

1. Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, Domene S, Velez JI, Karkera JD, Balog J, et al. 2010a. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 15: 1053-1066.
2. Arcos-Burgos M, Martinez AF, Acosta MT, Wallis D, de Leon J, Castellanos FX, Muenke M. 2010b. LPHN3 variants are associated to comorbid disruptive behavior disorders and substance use disorder. Manuscript in preparation.
3. Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201.
4. Bennett MK, Scheller RH. 1993. The molecular machinery for secretion is conserved from yeast to neurons. Proc Natl Acad Sci USA 90: 2559-2563.
5. Beyer RP, Fry RC, Lasarev MR, McConnachie LA, Meira LB, Palmer VS, Powell CL, Ross PK, Bammler TK, Bradford BU, et al. 2007. Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci 99: 326-337.
6. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366: 237-248.
7. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. 1995. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152: 1652-1658.
8. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV. 2006. Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med 36: 167-179.
9. Bin Sun H, Ruan Y, Xu ZC, Yokota H. 2002. Involvement of the calcium-independent receptor for alpha-latrotoxin in brain ischemia. Brain Res Mol Brain Res 104: 246-249.
10. Bjarnadottir TK, Fredriksson R, Schioth HB. 2007. The adhesion GPCRs: A unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci 64: 2104-2119.
11. Brose N, Rosenmund C, Rettig J. 2000. Regulation of transmitter release by Unc-13 and its homologues. Curr Opin Neurobiol 10: 303-311.
12. Bukstein O. 2008. Substance abuse in patients with attention-deficit/hyperactivity disorder. Medscape J Med 10: 24.
13. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE. 2003. Insights into G protein structure, function, and regulation. Endocr Rev 24: 765-781.
14. +-free solutions on the structure of the active zone. J Cell Biol 81: 163-177.
15. Crosby LM, Simmons JE, Ward WO, Moore TM, Morgan KT, Deangelo AB. 2008. Integrated disinfection by-products (DBP) mixtures research: gene expression alterations in primary rat hepatocyte cultures exposed to DBP mixtures formed by chlorination and ozonation/postchlorination. J Toxicol Environ Health A 71: 1195-1215.
16. +-independent alpha-latrotoxin-binding protein. J Biol Chem 271: 23239-23245.
17. +. EMBO J 17: 3909-3920.
18. de Maturana RL, Sanchez-Pernaute R. 2010. Regulation of corticostriatal synaptic plasticity by G protein-coupled receptors. CNS Neurol Disord Drug Targets 9: 601-615.
19. de Wilde J, Mohren R, van den Berg S, Boekschoten M, Dijk KW, de Groot P, Muller M, Mariman E, Smit E. 2008. Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. Physiol Genomics 32: 360-369.
20. Deaciuc IV, Arteel GE, Peng X, Hill DB, McClain CJ. 2004. Gene expression in the liver of rats fed alcohol by means of intragastric infusion. Alcohol 33: 17-30.
21. Deak F, Liu X, Khvotchev M, Li G, Kavalali ET, Sugita S, Sudhof TC. 2009. Alpha-latrotoxin stimulates a novel pathway of Ca2+-dependent synaptic exocytosis independent of the classical synaptic fusion machinery. J Neurosci 29: 8639-8648.
22. DeMilio L. 1989. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry 146: 1212-1214.
23. Dengjel J, Kratchmarova I, Blagoev B. 2009. Receptor tyrosine kinase signaling: A view from quantitative proteomics. Mol Biosyst 5: 1112-1121.
24. Deyev IE, Petrenko AG. 2010. Regulation of CIRL-1 proteolysis and trafficking. Biochimie 92: 418-422.
25. Dillman JF 3rd, Phillips CS, Dorsch LM, Croxton MD, Hege AI, Sylvester AJ, Moran TS, Sciuto AM. 2005. Genomic analysis of rodent pulmonary tissue following bis-(2-chloroethyl) sulfide exposure. Chem Res Toxicol 18: 28-34.
26. Doyle SE, Scholz MJ, Greer KA, Hubbard AD, Darnell DK, Antin PB, Klewer SE, Runyan RB. 2006. Latrophilin-2 is a novel component of the epithelial-mesenchymal transition within the atrioventricular canal of the embryonic chicken heart. Dev Dyn 235: 3213-3221.
27. Duan ZG, Yan XJ, He XZ, Zhou H, Chen P, Cao R, Xiong JX, Hu WJ, Wang XC, Liang SP. 2006. Extraction and protein component analysis of venom from the dissected venom glands of Latrodectus tredecimguttatus. Comp Biochem Physiol B Biochem Mol Biol 145: 350-357.
28. Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR Jr, Peles E. 2005. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 47: 215-229.
29. Fesce R, Segal JR, Ceccarelli B, Hurlbut WP. 1986. Effects of black widow spider venom and Ca2+ on quantal secretion at the frog neuromuscular junction. J Gen Physiol 88: 59-81.
30. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
31. Fukushima Y, Oshika Y, Tsuchida T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M. 1998. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol 13: 967-970.
32. Gether U, Asmar F, Meinild AK, Rasmussen SG. 2002. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol 91: 304-312.
33. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U, Kelly K. 1996. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157: 5438-5447.
34. Green ML, Klein TE. 2002. A multidomain TIGR/olfactomedin protein family with conserved structural similarity in the N-terminal region and conserved motifs in the C-terminal region. Mol Cell Proteomics 1: 394-403.
35. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
36. Gyorffy B, Surowiak P, Kiesslich O, Denkert C, Schafer R, Dietel M, Lage H. 2006. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer 118: 1699-1712.
37. Hamann J, Vogel B, van Schijndel GM, van Lier RA. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184: 1185-1189.
38. Harder A, Holden-Dye L, Walker R, Wunderlich F. 2005. Mechanisms of action of emodepside. Parasitol Res 97: S1-S10.
39. Hatanaka H, Oshika Y, Abe Y, Yoshida Y, Hashimoto T, Handa A, Kijima H, Yamazaki H, Inoue H, Ueyama Y, et al. 2000. Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). Int J Mol Med 5: 181-183.
40. Hattula K, Furuhjelm J, Tikkanen J, Tanhuanpaa K, Laakkonen P, Peranen J. 2006. Characterization of the Rab8-specific membrane traffic route linked to protrusion formation. J Cell Sci 119: 4866-4877.
41. Hausott B, Kurnaz I, Gajovic S, Klimaschewski L. 2009. Signaling by neuronal tyrosine kinase receptors: Relevance for development and regeneration. Anat Rec (Hoboken) 292: 1976-1985.
42. Hayflick JS. 2000. A family of heptahelical receptors with adhesion-like domains: A marriage between two super families. J Recept Signal Transduct Res 20: 119-131.
43. Heneweer M, Houtman R, Poortman J, Groot M, Maliepaard C, Peijnenburg A. 2007. Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach. Toxicol Sci 99: 303-314.
44. Hiramatsu H, Tadokoro S, Nakanishi M, Hirashima N. 2010. Latrotoxin-induced exocytosis in mast cells transfected with latrophilin. Toxicon (in press). DOI: 10.1016/j.toxicon.2010.08.002
45. Hlubek MD, Stuenkel EL, Krasnoperov VG, Petrenko AG, Holz RW. 2000. Calcium-independent receptor for alpha-latrotoxin and neurexin 1alpha [corrected] facilitate toxin-induced channel formation: Evidence that channel formation results from tethering of toxin to membrane. Mol Pharmacol 57: 519-528.
46. Horner BR, Scheibe KE. 1997. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry 36: 30-36.
47. +)-dependent exocytosis and sensitizes fusion machinery in endocrine cells. Acta Biochim Biophys Sin (Shanghai) 38: 8-14.
48. Ichtchenko K, Bittner MA, Krasnoperov V, Little AR, Chepurny O, Holz RW, Petrenko AG. 1999. A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors. J Biol Chem 274: 5491-5498.
49. Igarashi M, Ohyama A, Ohbayashi K, Kozaki S, Komiya Y. 2000. The mechanism of the neurotransmitter release in growth cones. J Neurosci Res 60: 743-753.
50. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. 2001. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 15: 43-58.
51. Junttila TT, Sundvall M, Maatta JA, Elenius K. 2000. Erbb4 and its isoforms: Selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10: 304-310.
52. Kang X, Xiao X, Harata M, Bai Y, Nakazaki Y, Soda Y, Kurita R, Tanaka T, Komine F, Izawa K, et al. 2006. Antiangiogenic activity of BAI1 in vivo: Implications for gene therapy of human glioblastomas. Cancer Gene Ther 13: 385-392.
53. Kopp J, Schwede T. 2004. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res 32: D230-234.
54. Kopp J, Schwede T. 2006. The SWISS-MODEL Repository: new features and functionalities. Nucleic Acids Res 34: D315-318.
55. Krain AL, Castellanos FX. 2006. Brain development and ADHD. Clin Psychol Rev 26: 433-444.
56. Krasnoperov VG, Beavis R, Chepurny OG, Little AR, Plotnikov AN, Petrenko AG. 1996. The calcium-independent receptor of alpha-latrotoxin is not a neurexin. Biochem Biophys Res Commun 227: 868-875.
57. Krasnoperov VG, Bittner MA, Beavis R, Kuang Y, Salnikow KV, Chepurny OG, Little AR, Plotnikov AN, Wu D, Holz RW, et al. 1997. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 18: 925-937.
58. Krasnoperov V, Lu Y, Buryanovsky L, Neubert TA, Ichtchenko K, Petrenko AG. 2002. Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J Biol Chem 277: 46518-46526.
59. Krasnoperov V, Deyev IE, Serova OV, Xu C, Lu Y, Buryanovsky L, Gabibov AG, Neubert TA, Petrenko AG. 2009. Dissociation of the subunits of the calcium-independent receptor of alpha-latrotoxin as a result of two-step proteolysis. Biochemistry 48: 3230-3238.
60. Kreienkamp HJ, Zitzer H, Gundelfinger ED, Richter D, Bockers TM. 2000. The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins. J Biol Chem 275: 32387-32390.
61. Kreienkamp HJ, Soltau M, Richter D, Bockers T. 2002. Interaction of G-protein-coupled receptors with synaptic scaffolding proteins. Biochem Soc Trans 30: 464-468.
62. Kuperman S, Schlosser SS, Kramer JR, Bucholz K, Hesselbrock V, Reich T, Reich W. 2001. Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. Am J Psychiatry 158: 2022-2026.
63. Landry Y, Gies JP. 2002. Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery. Mini Rev Med Chem 2: 361-372.
64. Langenhan T, Promel S, Mestek L, Esmaeili B, Waller-Evans H, Hennig C, Kohara Y, Avery L, Vakonakis I, Schnabel R, et al. 2009. Latrophilin signaling links anterior-posterior tissue polarity and oriented cell divisions in the C. elegans embryo. Dev Cell 17: 494-504.
65. Lee JH, Koh JT, Shin BA, Ahn KY, Roh JH, Kim YJ, Kim KK. 2001. Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer. Int J Oncol 18: 355-361.
66. Lelianova VG, Davletov BA, Sterling A, Rahman MA, Grishin EV, Totty NF, Ushkaryov YA. 1997. Alpha-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors. J Biol Chem 272: 21504-21508.
67. Matsushita H, Lelianova VG, Ushkaryov YA. 1999. The latrophilin family: Multiply spliced G protein-coupled receptors with differential tissue distribution. FEBS Lett 443: 348-352.
68. Millar RP, Newton CL. 2010. The year in G protein-coupled receptor research. Mol Endocrinol 24: 261-274.
69. Molina BS, Pelham WE Jr. 2003. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112: 497-507.
70. Molina BSG, Smith BH, Pelham WE. 1999. Interactive effects of attention deficit hyperactivity disorder and conduct disorder on early adolescent substance use. Psychol Addict Behav 13: 348-358.
71. Moreno TA, Bronner-Fraser M. 2001. The secreted glycoprotein Noelin-1 promotes neurogenesis in Xenopus. Dev Biol 240: 340-360.
72. Naciff JM, Jump ML, Torontali SM, Carr GJ, Tiesman JP, Overmann GJ, Daston GP. 2002. Gene expression profile induced by 17alpha-ethynyl estradiol. bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68: 184-199.
73. Naciff JM, Hess KA, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Foertsch LM, Richardson BD, Martinez JE, Daston GP. 2005. Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol. genistein, or bisphenol A. Toxicol Sci 86: 396-416.
74. Nechiporuk T, Urness LD, Keating MT. 2001. ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. J Biol Chem 276: 4150-4157.
75. Palacio JD, Castellanos FX, Pineda DA, Lopera F, Arcos-Burgos M, Quiroz YT, Henao GC, Puerta IC, Ramirez DL, Rapoport JL, et al. 2004. Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families. J Am Acad Child Adolesc Psychiatry 43: 1506-1515.
76. Peitsch MC. 1995. Protein modeling by E-mail. Bio/Technology 13: 658-660.
77. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3: 639-650.
78. Plant KE, Anderson E, Simecek N, Brown R, Forster S, Spinks J, Toms N, Gibson GG, Lyon J, Plant N. 2009. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol 235: 124-134.
79. Popova NV, Plotnikov A, Deev IE, Petrenko AG. 2007. Interaction of calcium-independent latrotoxin receptor with intracellular adapter protein TRIP8b. Dokl Biochem Biophys 414: 149-151.
80. Rahman MA, Ashton AC, Meunier FA, Davletov BA, Dolly JO, Ushkaryov YA. 1999. Norepinephrine exocytosis stimulated by alpha-latrotoxin requires both external and stored Ca2+ and is mediated by latrophilin, G proteins and phospholipase C. Philos Trans R Soc Lond B Biol Sci 354: 379-386.
81. Ribases M, Bosch R, Hervas A, Ramos-Quiroga JA, Sanchez-Mora C, Bielsa A, Gastaminza X, Guijarro-Domingo S, Nogueira M, Gomez-Barros N, et al. 2009. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: Association of BAIAP2 with attention-deficit/hyperactivity disorder. Biol Psychiatry 66: 926-934.
82. Rogers S, Wells R, Rechsteiner M. 1986. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 234: 364-368.
83. Roland JT, Kenworthy AK, Peranen J, Caplan S, Goldenring JR. 2007. Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. Mol Biol Cell 18: 2828-2837.
84. Rosenthal L, Meldolesi J. 1989. Alpha-latrotoxin and related toxins. Pharmacol Ther 42: 115-134.
85. +)-independent effects mediated by the toxin. Mol Pharmacol 38: 917-923.
86. Roth AF, Sullivan DM, Davis NG. 1998. A large PEST-like sequence directs the ubiquitination, endocytosis, and vacuolar degradation of the yeast a-factor receptor. J Cell Biol 142: 949-961.
87. Schoneberg T, Schulz A, Gudermann T. 2002. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol 144: 143-227.
88. Schwede T, Kopp J, Guex N, Peitsch MC. 2003. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385.
89. Secher T. 2010. Soluble NCAM. Adv Exp Med Biol 663: 227-242.
90. Sekhar KR, Freeman ML. 1998. PEST sequences in proteins involved in cyclic nucleotide signalling pathways. J Recept Signal Transduct Res 18: 113-132.
91. Shiratsuchi T, Nishimori H, Ichise H, Nakamura Y, Tokino T. 1997. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet Cell Genet 79: 103-108.
92. Silva JP, Lelianova V, Hopkins C, Volynski KE, Ushkaryov Y. 2009a. Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors. J Biol Chem 284: 6495-6506.
93. Silva JP, Suckling J, Ushkaryov Y. 2009b. Penelope's web: Using alpha-latrotoxin to untangle the mysteries of exocytosis. J Neurochem 111: 275-290.
94. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. 2008. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One 3: e3745.
95. Stacey M, Lin HH, Gordon S, McKnight AJ. 2000. LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. Trends Biochem Sci 25: 284-289.
96. Stacey M, Chang GW, Sanos SL, Chittenden LR, Stubbs L, Gordon S, Lin HH. 2002. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J Biol Chem 277: 29283-29293.
97. Sudhof TC. 2001. alpha-Latrotoxin and its receptors: Neurexins and CIRL/latrophilins. Annu Rev Neurosci 24: 933-962.
98. Sugita S, Ichtchenko K, Khvotchev M, Sudhof TC. 1998. alpha-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors. G-protein coupling not required for triggering exocytosis. J Biol Chem 273: 32715-32724.
99. Suzuki J, Ikeda T, Kuroyama H, Seki S, Kasai M, Utsuyama M, Tatsumi M, Uematsu H, Hirokawa K. 2004. Regulation of osteoclastogenesis by three human RANKL isoforms expressed in NIH3T3 cells. Biochem Biophys Res Commun 314: 1021-1027.
100. Szobot CM, Rohde LA, Bukstein O, Molina BS, Martins C, Ruaro P, Pechansky F. 2007. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. Addiction 102: 1122-1130.
101. Szurmant H, White RA, Hoch JA. 2007. Sensor complexes regulating two-component signal transduction. Curr Opin Struct Biol 17: 706-715.
102. Tabata Y, Khurana Hershey GK. 2007. IL-13 receptor isoforms: Breaking through the complexity. Curr Allergy Asthma Rep 7: 338-345.
103. Tobaben S, Sudhof TC, Stahl B. 2002. Genetic analysis of alpha-latrotoxin receptors reveals functional interdependence of CIRL/latrophilin 1 and neurexin 1 alpha. J Biol Chem 277: 6359-6365.
104. Tomita M, Okuyama T, Hidaka K, Ishikawa T, Adachi J, Nohno T. 2004. Early differential gene expression of rat lung after exposure to paraquat. Free Radic Res 38: 821-829.
105. Tsuda H, Sasai N, Matsuo-Takasaki M, Sakuragi M, Murakami Y, Sasai Y. 2002. Dorsalization of the neural tube by Xenopus tiarin, a novel patterning factor secreted by the flanking nonneural head ectoderm. Neuron 33: 515-528.
106. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo LC, Berova N, Nakanishi K, Haber E, et al. 1993. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA 90: 8189-8193.
107. Ushkaryov YA, Rohou A, Sugita S. 2008. alpha-Latrotoxin and its receptors. Handb Exp Pharmacol 184: 171-206.
108. Vakonakis I, Langenhan T, Promel S, Russ A, Campbell ID. 2008. Solution structure and sugar-binding mechanism of mouse latrophilin-1 RBL: A 7TM receptor-attached lectin-like domain. Structure 16: 944-953.
109. Van Renterghem C, Iborra C, Martin-Moutot N, Lelianova V, Ushkaryov Y, Seagar M. 2000. alpha-latrotoxin forms calcium-permeable membrane pores via interactions with latrophilin or neurexin. Eur J Neurosci 12: 3953-3962.
110. Verhage M, Maia AS, Plomp JJ, Brussaard AB, Heeroma JH, Vermeer H, Toonen RF, Hammer RE, van den Berg TK, Missler M, et al. 2000. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287: 864-869.
111. Volynski KE, Meunier FA, Lelianova VG, Dudina EE, Volkova TM, Rahman MA, Manser C, Grishin EV, Dolly JO, Ashley RH, et al. 2000. Latrophilin, neurexin, and their signaling-deficient mutants facilitate alpha-latrotoxin insertion into membranes but are not involved in pore formation. J Biol Chem 275: 41175-41183.
112. Volynski KE, Silva JP, Lelianova VG, Atiqur Rahman M, Hopkins C, Ushkaryov YA. 2004. Latrophilin fragments behave as independent proteins that associate and signal on binding of LTX(N4C). EMBO J 23: 4423-4433.
113. White GR, Varley JM, Heighway J. 1998. Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer. Oncogene 17: 3513-3519.
114. Willson J, Amliwala K, Davis A, Cook A, Cuttle MF, Kriek N, Hopper NA, O'Connor V, Harder A, Walker RJ, et al. 2004. Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans. Curr Biol 14: 1374-1379.
115. Xing Y, Nakamura Y, Rainey WE. 2009. G protein-coupled receptor expression in the adult and fetal adrenal glands. Mol Cell Endocrinol 300: 43-50.
116. Yamada S, Shiro Y. 2008. Structural basis of the signal transduction in the two-component system. Adv Exp Med Biol 631: 22-39.
117. Zhang H, Dong Y, Zhao H, Brooks JD, Hawthorn L, Nowak N, Marshall JR, Gao AC, Ip C. 2005. Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. Cancer Genomics Proteomics 2: 97-9114.